Skip to main content

A breath of fresh money for migraine treatment

OptiNose signed a licensing deal worth up to $110 million for its experimental migraine headache treatment...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.